Following co-incubation, DCs were activated with LPS treatment and intraperitoneally injected into tumor-bearing B6 WT or Mertk-/-V1 mice on days 14 and 21 after tumor implantation (Figure 5C). The gene discussed is MERTK; the disease is neoplasm.